Histone H4R3me2a Antibody | CSB-PA953294

(No reviews yet) Write a Review
SKU:
CSB-PA953294
Availability:
3 to 7 Working Days
Size:
100ul
€601.80

Description

Histone H4R3me2a Antibody | CSB-PA953294 | Cusabio

Histone H4R3me2a Antibody is Available at Gentaur Genprice with the fastest delivery.

Online Order Payment is possible or send quotation to info@gentaur.com.

Product Type: Polyclonal Antibody

Target Names: HIST3H3

Aliases: H3t; H3.4; H3/g; H3FT;

Background: Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4) . The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene is intronless and encodes a member of the histone H4 family. Transcripts from this gene lack polyA tails; instead, they contain a palindromic termination element.

Isotype: IgG

Conjugate: Non-conjugated

Clonality: Polyclonal

Uniport ID: Q16695

Host Species: Rabbit

Species Reactivity: Human, Mouse, Rat

Immunogen: A synthetic methylated peptide corresponding to residues surrounding Arg3 of human histone H4

Immunogen Species: Human

Applications: ELISA, WB, IF, IP, ChIP

Tested Applications: ELISA, WB, IF, IP, ChIP;WB:1:500-1:2000, IF:1:50-1:200, IP:1:50-1:200, ChIP:1:50-1:200

Purification Method: Antigen Affinity Purified

Dilution Ratio1: ELISA:1:2000-1:10000

Dilution Ratio2: WB:1:500-1:2000

Dilution Ratio3: IF:1:50-1:200

Dilution Ratio4: IP:1:50-1:200

Dilution Ratio5: ChIP:1:50-1:200

Dilution Ratio6:

Buffer: Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Form: liquid

Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Initial Research Areas: Epigenetics and Nuclear Signaling

Research Areas: Epigenetics & Nuclear Signaling

View AllClose

0 Reviews

View AllClose